Statistics
Publications
6
Citations
259
H-Index
6
Active since
2003
Godwin Kumi is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, drug discovery, and medicine.
Publications per year
2003–2021
6
6
Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor
Dan You, Stephen Hillerman, Gregory Locke et al. · Journal for ImmunoTherapy of Cancer · 2021 · 76 citations · Full text
Medicine, Immunology, Pharmacology +17
Benjamin W. Gung, Godwin Kumi · The Journal of Organic Chemistry · 2003 · 29 citations
1–5 of 6